Phytoestrogens induce apoptosis through a mitochondria/caspase pathway in human breast cancer cells

References

• Ganry O. Phytoestrogen and breast cancer prevention. Eur J Cancer Prev 2002;11:519–22
   PubMed Web of Science ®Google Scholar
• Ingram D, Sanders K, Kolybaba M, Lopez D. Case-control study of phyto-estrogens and breast cancer. Lancet 1997;350: 990–4
   PubMed Web of Science ®Google Scholar
• Shu X-O, Jin F, Dai Q, et al. Soyfood intake during adolescence and subsequent risk of breast cancer among Chinese women. Cancer Epidemiol Biomarkers Prev 2001; 10:483–8
   PubMed Web of Science ®Google Scholar
• Murkies A, Dalais FS, Briganti E, et al. Phytoestrogens and breast cancer in postmenopausal women: a case control study. Menopause 2000;7:289–96
   PubMed Web of Science ®Google Scholar
• Key T, Sharp G, Appleby P, et al. Soya foods and breast cancer risk: a prospective study in Hiroshima and Nagasaki, Japan. Br J Cancer 1999;81:1248–56
   PubMed Web of Science ®Google Scholar
• den Tonkelaar I, Keinan-Boker L, Van’t Veer P, et al. Urinary phytoestrogens and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev 2001;10:223–8
   PubMed Web of Science ®Google Scholar
• Horn-Ross P, Hoggatt KJ, West DW, et al. Recent diet and breast cancer risk: the California Teachers Study (USA). Cancer Causes Control 2002;13:407–15
   PubMed Web of Science ®Google Scholar
• Grace PB, Taylor JI, Low YL, et al. Phytoestrogen concentrations in serum and spot urine as biomarkers for dietary phytoestrogen intake and their relation to breast cancer risk in European prospective investigation of cancer and nutrition, Norfolk. Cancer Epidemiol Biomarkers Prev 2004;13:698–708
   PubMed Web of Science ®Google Scholar
• Benassayag C, Perrot-Applanat M, Ferre F. Phytoestrogens as modulators of steroid action in target cells. J Chromatogr B Analyt Technol Biomed Life Sci 2002;777:233–48
   PubMed Web of Science ®Google Scholar
• Tuohy PG. Soy infant formula and phytoestrogens. J Paediatr Child Health 2003;39:401–5
   PubMed Web of Science ®Google Scholar
• Pozo-Guisado E, Alvarez-Barrientos A, Mulero-Navarro S, Santiago-Josefat B, Fernandez-Salguero PM. The antiproliferative activity of resveratrol results in apoptosis in MCF-7 but not in MDA-MB-231 human breast cancer cells: cell-specific alteration of the cell cycle. Biochem Pharmacol 2002; 64: 1375–86
   PubMed Web of Science ®Google Scholar
• Pozo-Guisado E, Merino JM, Mulero-Navarro S, et al. Resveratrol-induced apoptosis in MCF-7 human breast cancer cells involves a caspase-independent mechanism with downregulation of Bcl-2 and NF-kappaB. Int J Cancer 2005;115:74–84
   PubMed Web of Science ®Google Scholar
• Seo HS, Denardo DG, Jacquot Y, et al. Stimulatory effect of genistein and apigenin on the growth of breast cancer cells correlates with their ability to activate ER alpha. Breast Cancer Res Treat 2006;99:121–34
   PubMed Web of Science ®Google Scholar
• Schmitt E, Lehmann L, Metzler M, Stopper H. Hormonal and genotoxic activity of resveratrol. Toxicol Lett 2002;136: 133–42
   PubMed Web of Science ®Google Scholar
• van der Woude H, Ter Veld MG, Jacobs N, van der Saag PT, Murk AJ, Rietjens IM. The stimulation of cell proliferation by quercetin is mediated by the estrogen receptor. Mol Nutr Food Res 2005;49:763–71
   PubMed Web of Science ®Google Scholar
• Devarajan E, Sahin AA, Chen JS, et al. Down-regulation of caspase 3 in breast cancer: a possible mechanism for chemoresistance. Oncogene 2002;21:8843–51
   PubMed Web of Science ®Google Scholar
• Yang S, Zhou Q, Yang X. Caspase-3 status is a determinant of the differential responses to genistein between MDA-MB-231 and MCF-7 breast cancer cells. Biochim Biophys Acta 2007; 1773:903–11
   PubMed Web of Science ®Google Scholar
• Scarlatti F, Maffei R, Beau I, Codogno P, Ghidoni R. Role of non-canonical Beclin 1-independent autophagy in cell death induced by resveratrol in human breast cancer cells. Cell Death Differ 2008;15:1318–29
   PubMed Web of Science ®Google Scholar
• Deepa M, Sureshkumar T, Satheeshkumar PK, Priya S. Antioxidant rich Morus alba leaf extract induces apoptosis in human colon and breast cancer cells by the downregulation of nitric oxide produced by inducible nitric oxide synthase. Nutr Cancer 2013;65:305–10
   PubMed Web of Science ®Google Scholar
• Hill MM, Hemmings BA. Inhibition of protein kinase B/Akt. Implications for cancer therapy. Pharmacol Ther 2002;93:243–51
   PubMed Web of Science ®Google Scholar
• Lee YK, Park OJ. Regulation of mutual inhibitory activities between AMPK and Akt with quercetin in MCF-7 breast cancer cells. Oncol Rep 2010;24:1493–7
   PubMed Web of Science ®Google Scholar
• Gong L, Li Y, Nedeljkovic-Kurepa A, Sarkar FH. Inactivation of NF-kappaB by genistein is mediated via Akt signaling pathway in breast cancer cells. Oncogene 2003;24:4702–9
   Web of Science ®Google Scholar
• Schmitz I, Kirchhoff S, Krammer PH. Regulation of death receptor-mediated apoptosis pathways. Int J Biochem Cell Biol 2000; 32:1123–36
   PubMed Web of Science ®Google Scholar
• Dejean LM, Martinez-Caballero S, Manon S, Kinnally KW. Regulation of the mitochondrial apoptosis-induced channel, MAC, by BCL-2 family proteins. Biochim Biophys Acta 2006; 1762:191–201
   PubMed Web of Science ®Google Scholar
• Gompel A, Somai S, Chaouat M, et al. Hormone regulation of apoptosis in breast cells and tissue. Steroids 2000;65:593–8
   PubMed Web of Science ®Google Scholar
• McDonnell DP. The molecular determinants of estrogen receptor pharmacology. Maturitas 2004;48(Suppl 1):S7–12
   PubMed Web of Science ®Google Scholar
• Omoto Y, Eguchi H, Yamamoto-Yamaguchi Y, Hayashi S. Estrogen receptor (ER) beta1 and ERbetacx/beta2 inhibit ERalpha function differently in breast cancer cell line MCF7. Oncogene 2003;22:5011–20
   PubMed Web of Science ®Google Scholar
• Strom A, Hartman J, Foster JS, Kietz S, Wimalasena J, Gustafsson JA. Estrogen receptor beta inhibits 17beta-estradiol-stimulated proliferation of the breast cancer cell line T47D. Proc Natl Acad Sci USA 2004;101:1566–71
   PubMed Web of Science ®Google Scholar
• Koehler KF, Helguero LA, Haldosen LA, Warner M, Gustafsson JA. Reflections on the discovery and significance of estrogen receptor beta. Endocr Rev 2005;26:465–78
   PubMed Web of Science ®Google Scholar
• Morton MS, Wilcox G, Wahlqvist ML, Griffiths K. Determination of lignans and isoflavonoids in human female plasma following dietary supplementation. J Endocrinol 1994;142:251–9
   PubMed Web of Science ®Google Scholar
• Setchell KD, Zimmer-Nechemias L, Cai J, Heubi JE. Exposure of infants to phyto-oestrogens from soy-based infant formula. Lancet 1997;350:23–7
   PubMed Web of Science ®Google Scholar
• Harris DM, Besselink E, Henning SM, Go VLW, Heber D. Phytoestrogens induce differential estrogen receptor alpha- or beta-mediated responses in transfected breast cancer cells. Exp Biol Med 2005;230:558–68
   PubMed Web of Science ®Google Scholar
• Maggiolini M, Bonofiglio D, Marsico S, et al. Estrogen receptor alpha mediates the proliferative but not the cytotoxic dose- dependent effects of two major phytoestrogens on human breast cancer cells. Mol Pharmacol 2001;60:595–602
   PubMed Web of Science ®Google Scholar